Skip to main content

Why are the billionaires always laughing?

Because they know the corporate media will never call bullshit on their bullshit.

Why are the billionaires laughing?

It’s easy to laugh when the corporate press treats you as a glorious success instead of the epitome of a broken social order. Billionaires laugh because they know the corporate media prefers to fawn over them rather than hold them to account.

Today, we ask you to support our nonprofit, independent journalism because we are not impressed by billionaires flying into space, their corporations despoiling our health and planet, or their vast fortunes safely concealed in tax havens across the globe. We are not laughing.

We are hard at work producing journalism for the common good. With our Fall Campaign underway, please support this mission today. We cannot do it without you.

Support Our Work -- Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Every donation—large or small—helps us bring you the news that matters.

Medical professionals, medical students, ACTUP New York, and their supporters held a rousing protest rally outside Pfizer World Headquarters in New York. At the beginning of 2019, the corporate giant announced price increases for 40 of its drugs. (Photo: Erik McGregor/Pacific Press/LightRocket via Getty Images)

Medical professionals, medical students, ACTUP New York, and their supporters held a rousing protest rally outside Pfizer World Headquarters in New York. At the beginning of 2019, the corporate giant announced price increases for 40 of its drugs. (Photo: Erik McGregor/Pacific Press/LightRocket via Getty Images)

'No One Should Be Fooled': Trump Executive Order on Drug Prices Denounced as Election Year Charade

Latest move called nothing more than a public relations stunt "intended to distract Americans from the president's broken promises to seniors and the 200,000 Americans that have died from the coronavirus as a result of his failed Covid-19 response policies."

Jon Queally

Advocates for lowering drug prices in the United States are raising alarm over an executive order issued by President Donald Trump on Sunday that the White House purports would challenge the nation's pharmaceutical industry but which critics say is just an election year ploy to make it look like the president is finally following through on a 2016 campaign promise he has neglected throughout his term.

"No one should be fooled by President Trump's latest charade on drug prices. After three and a half years of endless empty rhetoric, Americans have seen their prescription drug prices go up, not down."
—Lower Drug Prices Now

The executive order itself would require that the secretary of Health and Human Services to "immediately" explore implementing a payment model for Medicare to pay "no more than the most-favored-nation price," which means the lowest price paid in other developed countries, for specific "high-cost" prescription medicines. While Trump celebrated the order as a far-reaching game-changer, experts said the move will likely have any little if any meaningful impact.

"The proposed executive order would appear to be of limited immediate effect," reported the Wall Street Journal. "Experts see the order as the administration’s effort to show it is taking steps to lower drug pricing, as the president seeks reelection. Drug-pricing experts say that the best way to lower prices under Medicare is to grant the agency the legal authority to directly negotiate prices with drug companies. This measure wouldn't do that."

While much of the reporting on Trump's order focused on how "controversial" the bill was due to its cold reception by the powerful drug industry, Peter Maybarduk, director of the global access to medicines program at Public Citizen, was critical of the order precisely because Big Pharma will likely walk all over it by voicing the kind of challenges it issued upon Trump's announcement on Sunday.

According to Maybarduk, "European countries pay less because they negotiate and set basic disciplines on the prices that drug monopolists can charge. A direct way to lower medicine prices in the U.S. would be to give Medicare negotiation powers, as candidate Trump pledged back in 2016."

As NPR reports:

The new executive order repeals the original and expands the drugs covered by Trump's proposed "most favored nations" pricing scheme to include both Medicare Part B and Medicare Part D. The idea is that Medicare would refuse to pay more for drugs than the lower prices paid by other developed nations.

"It is unacceptable that Americans pay more for the exact same drugs, often made in the exact same places," the executive order declares.

Maybarduk warned in a tweet that the pharmaceutical industry "isn’t going to suddenly start playing ball. Pharma will challenge rules that come out of the order. Also, the EO indicates what USG should pay, but does not appear to regulate what corporations charge."

"This is a massive win for the drug industry and another broken drug pricing promise by President Trump," said Eli Zupnick, spokesman for Accountable Pharma, in a statement Monday. "The drug industry is going to act like this weak executive order is a horrific injustice but the reality is that they were wildly successful in lobbying their former colleagues in the Administration to delay and water down this executive order to the point where it almost certainly won't save a single American a single penny on their prescription drugs."

Other critics of the move said it reeked of election year politics, with some suggesting that it should do more to expose how little Trump has done on the issue—and the low priority its been given by an administration that has shown little regard to protecting public health or improving access to more affordable medications.

"President Trump's executive order on drug pricing does not by itself do anything. It has to be followed up by regulations, which will take time," warned Larry Levitt of the Kaiser Family Foundation in a tweet. "Trump has a history of bold talk on drug prices, only to pull back when it comes to putting actual regulations in place."

Lower Drug Prices Now, an advocacy coalition of national and state-level affiliates which calls for lower and affordable drug prices for all Americans, warned that Trump's order should be seen for the reelection ploy by Trump that it is.

"No one should be fooled by President Trump's latest charade on drug prices," the group said in a Sunday night statement. "After three and a half years of endless empty rhetoric, Americans have seen their prescription drug prices go up, not down."

The group called the order nothing more than a public relations stunt "intended to distract Americans from the president's broken promises to seniors and the 200,000 Americans that have died from the coronavirus as a result of his failed Covid-19 response policies."

According to Axios' reporter Caitlin Owens, "given that he's had four years already to act on what was also a big issue in 2016, there's plenty of reason to be skeptical of this ever translating into official policy."

In December of last year, House Democrats passed H.R. 3, The Elijah Cummings Lower Drug Costs Now Act, by a vote of 230 to 192. While Senator Majority Leader Mitch McConnell refused to take it up in the Senate—and received no support from the Trump White House—the legislation would have led to dramatically lower prescription drug costs nationwide and much further-reaching protections and benefits for Americans overall.

"A serious proposal to lower RX prices & take away drug corporations' monopoly power to charge whatever they want requires coordinated action from Congress—like the Medicare negotiations bill that President Trump rejected last year which included international price indexing," said Lower Drug Prices Now in its statement, referring to HR 3. "It's clear that this President is more interested in photo ops than passing laws to take on Big Pharma."

Peter Morley, a patient advocate, similarly met the announcement by the Trump administration with both anger and heartbreak.

"A PR stunt designed as an executive order on the affordability of prescription drugs does NOTHING," Morley tweeted. "Critical and chronically ill patients can still die by the lack of accessibility. It's just a game to this Administration. Sickening, LITERALLY."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Israel Condemned for Designating Palestinian Human Rights Groups 'Terrorist Organizations'

"Labeling effective NGOs 'terrorists' is a textbook way to evade accountability for human rights violations—and an affront to everyone who cares about peace," said Rep. Ilhan Omar.

Kenny Stancil ·


House Progressives Call On Biden to Declare a Climate Emergency—Now

"Your inaction," Rep. Cori Bush warned the president, "is undermining our efforts to deliver good jobs, environmental justice, and a renewable energy future."

Jessica Corbett ·


Despite Politicians and Pundits' Claims, Twitter Finds Algorithm Favors Right-Wing Voices

"So much for Trump's claim that Twitter has an anti-conservative bias."

Brett Wilkins ·


'And Maybe More': Biden Says He's Open to Reforming Filibuster to Win Voting Rights

"It's a simple choice between a free America or one chained by the past," said one advocate. "Our democracy hangs in the balance."

Julia Conley ·


Carbon Offsets Are Nothing But a 'Dangerous' Con Job, Warns Climate Group

"The best way to prevent the heating of our planet," says Friends of the Earth, "is to end the use of fossil fuels for good."

Andrea Germanos ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo